The China Mail - US authorizes first condom for use in anal sex

USD -
AED 3.672497
AFN 62.999908
ALL 82.732897
AMD 367.370222
ANG 1.790403
AOA 916.999726
ARS 1479.022976
AUD 1.451126
AWG 1.80125
AZN 1.700068
BAM 1.716442
BBD 2.015885
BDT 123.112028
BGN 1.69088
BHD 0.377375
BIF 2972.662249
BMD 1
BND 1.295099
BOB 6.916495
BRL 5.171902
BSD 1.000921
BTN 93.946202
BWP 13.602176
BYN 2.902892
BYR 19600
BZD 2.012989
CAD 1.41942
CDF 2267.499569
CHF 0.809845
CLF 0.023439
CLP 922.489761
CNY 6.79815
CNH 6.80298
COP 3439.65
CRC 454.429769
CUC 1
CUP 26.5
CVE 96.770372
CZK 21.276996
DJF 178.235113
DKK 6.56418
DOP 58.809075
DZD 133.424898
EGP 49.561298
ERN 15
ETB 161.36601
EUR 0.87818
FJD 2.266102
FKP 0.757679
GBP 0.757625
GEL 2.645016
GGP 0.757679
GHS 11.285269
GIP 0.757679
GMD 72.999567
GNF 8770.020624
GTQ 7.63614
GYD 209.469481
HKD 7.84203
HNL 26.780464
HRK 6.615899
HTG 130.8175
HUF 310.931025
IDR 17837
ILS 3.00205
IMP 0.757679
INR 94.36055
IQD 1311.158892
IRR 1375249.999747
ISK 126.459585
JEP 0.757679
JMD 157.637457
JOD 0.708966
JPY 161.749814
KES 129.469659
KGS 87.449866
KHR 4017.727851
KMF 434.000183
KPW 900.00035
KRW 1537.784438
KWD 0.30961
KYD 0.834087
KZT 485.637808
LAK 21969.371188
LBP 89630.523498
LKR 336.443021
LRD 182.31603
LSL 16.452675
LTL 2.95274
LVL 0.60489
LYD 6.42503
MAD 9.385493
MDL 17.746281
MGA 4233.621484
MKD 54.091886
MMK 2099.260826
MNT 3579.633879
MOP 8.085217
MRU 39.945588
MUR 47.719936
MVR 15.449437
MWK 1735.574181
MXN 17.511385
MYR 4.087987
MZN 63.894249
NAD 16.452675
NGN 1378.739811
NIO 36.83356
NOK 9.945915
NPR 150.313748
NZD 1.773185
OMR 0.384502
PAB 1.000921
PEN 3.41305
PGK 4.39247
PHP 61.296007
PKR 278.550353
PLN 3.76523
PYG 6109.087718
QAR 3.648427
RON 4.602603
RSD 103.014612
RUB 78.961553
RWF 1465.794901
SAR 3.758743
SBD 8.051953
SCR 14.057835
SDG 600.000277
SEK 9.73693
SGD 1.294515
SHP 0.746601
SLE 24.818945
SLL 20969.503664
SOS 572.030366
SRD 37.482991
STD 20697.981008
STN 21.501602
SVC 8.757734
SYP 110.532098
SZL 16.443021
THB 33.421313
TJS 9.263329
TMT 3.5
TND 2.966607
TOP 2.40776
TRY 46.623199
TTD 6.802405
TWD 31.862031
TZS 2629.994966
UAH 44.926675
UGX 3673.702225
UYU 40.177279
UZS 12022.46698
VES 620.752985
VND 26300
VUV 119.209429
WST 2.780882
XAF 575.678617
XAG 0.017063
XAU 0.000246
XCD 2.70255
XCG 1.803853
XDR 0.715959
XOF 575.678617
XPF 104.664531
YER 238.625049
ZAR 16.470505
ZMK 9001.226049
ZMW 18.029751
ZWL 321.999592
  • CMSC

    -0.1160

    21.93

    -0.53%

  • JRI

    0.2100

    12.79

    +1.64%

  • CMSD

    -0.1600

    21.77

    -0.73%

  • BCC

    1.2600

    81.02

    +1.56%

  • BCE

    -0.2800

    22.92

    -1.22%

  • RIO

    -1.3700

    93.74

    -1.46%

  • RBGPF

    3.7000

    65

    +5.69%

  • NGG

    -0.4100

    83.01

    -0.49%

  • GSK

    0.6100

    52.5

    +1.16%

  • BTI

    0.2800

    62.76

    +0.45%

  • RYCEF

    0.3900

    18.39

    +2.12%

  • AZN

    2.7300

    188.41

    +1.45%

  • RELX

    0.4200

    31.34

    +1.34%

  • VOD

    0.0300

    13.89

    +0.22%

  • BP

    -0.5900

    37.13

    -1.59%

US authorizes first condom for use in anal sex
US authorizes first condom for use in anal sex

US authorizes first condom for use in anal sex

The US Food and Drug Administration (FDA) on Wednesday authorized the first condom for use during anal intercourse, in what was hailed as a victory for sexual health by experts.

Text size:

Although people already use condoms for anal sex -- as is recommended by health agencies including the Centers for Disease Control and Prevention (CDC) -- regulators across the world had only previously allowed companies to officially market their products as "safe and effective" for vaginal use.

Sexual health advocates considered this an unmet public health need since unprotected anal intercourse carries the greatest risk of HIV transmission via sexual exposure, with one study finding that 69 percent of men who have sex with men would use condoms more frequently if they were FDA-indicated.

Wednesday's authorization of Global Protection Corp's One Male Condom follows a clinical trial involving more than 500 people, carried out by Emory University.

"The FDA's authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse," said agency scientist Courtney Lias in a statement.

The condom is also indicated to prevent sexually transmitted infections -- and as a contraceptive -- during vaginal sex.

"We want people to have lots of sex -- but we also want them to be empowered and informed," said Davin Wedel, president of Global Protection Corp, which makes the condom brand that is available in 54 sizes, and incorporates a paper template to help each user find the right size.

The clinical trial involved 252 men who have sex with men and 252 men who have sex with women, aged between 18 and 54.

The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish. The limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal and 1.89 percent for vaginal intercourse.

The researchers behind the study, which was published in The Lancet's eClinicalMedicine, said one of the reasons the trial succeeded where others failed in the past was likely due to the provision of lubricant and inclusion of instructions on how to use the product.

Lubricant reduces friction, which in turn causes condom failure from slippage and breakage.

Another reason could be that participants were asked to keep mobile phone-based daily diaries, whereas past trials had asked volunteers to recall failure events up to several months later.

Monica Gandhi, an infectious disease doctor and medical director of an HIV clinic in San Francisco, welcomed the finding.

"The important thing about condoms is they don't just prevent HIV, but they prevent gonorrhea, chlamydia and syphilis," she told AFP, adding it was surprising that such an authorization had taken so long to achieve.

In its statement, the FDA said the green light could pave the way for more makers to apply for similar authorization if they show equivalent results.

D.Pan--ThChM